Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplivanserin in sleep maintenance insomnia
NCT00308503Phase 3Completed
- Sponsor
- Sanofi
- Start
- Feb 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of eplivanserin in Insomnia, sponsored by Sanofi. Started Feb 2006; status: completed.
02
Drugs
eplivanserin
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00308503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00308503.